Injection site reactions : Mild reactions such as redness, itching, or discomfort at the injection site may occur but are generally transient
Sample member ID card for illustration only
FDAs 2025 Increase in Warning Letters on Compounded Drug Advertising In recent remarks at the Food and Drug Law Institutes Enforcement, Litigation, and Compliance Conference, the director of the Office of Compliance within FDAs Center for Drug Evaluation and Research's (CDER) noted that 22% of warning letters that CDER issued in fiscal year (FY) 2025 were sent to telehealth platforms and other entities related to claims made regarding compounded drug products, including compounded GLP-1s
After the indicated time of treatment, cells were maintained without test materials for 10 days
Biosimilar contracting requires a state-specific substitution analysis before committing to market share conversion targets
More than 500 of these students qualified for free or reduced lunch according to Nebraska Department of Education data